Yongjun Peng Selected Research

Yongjun Peng Research Topics

6	Neoplasms (Cancer) 01/2022 - 01/2020
2	Ischemic Stroke 12/2023 - 11/2023
2	Inflammation (Inflammations) 12/2023 - 11/2023
2	Stroke (Strokes) 11/2023 - 05/2018
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hip Dislocation 01/2022
1	Cerebral Infarction 05/2018
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 09/2015
1	Diarrhea 09/2015
1	Reperfusion Injury 12/2012
1	Brain Ischemia (Cerebral Ischemia) 12/2012

2	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021 - 11/2021
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	IronIBA 11/2023
1	AntioxidantsIBA 11/2023
1	NF-E2-Related Factor 2IBA 11/2023
1	Bromelains (Bromelain)IBA 01/2022
1	ferrous sulfideIBA 01/2022
1	EnzymesIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	InterferonsIBA 01/2022
1	Carbon MonoxideIBA 12/2021
1	HydrogenIBA 12/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2021
1	ProdrugsIBA 12/2021
1	Sulfur DioxideIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	Glutathione (Reduced Glutathione)IBA 11/2021
1	AcidsIBA 11/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 09/2015
1	Messenger RNA (mRNA)IBA 12/2012

5	Therapeutics 12/2023 - 05/2018
2	Aftercare (After-Treatment) 01/2022 - 05/2018
2	Prostheses and Implants (Prosthesis) 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2020
1	Immunotherapy 01/2022
1	Hemipelvectomy 01/2022
1	Radiotherapy 12/2021
1	Photochemotherapy (Photodynamic Therapy) 12/2021
1	Acupuncture Therapy 01/2020
1	Electroacupuncture 12/2012